NuCana plc (NCNA) Stock Price

1.59 ▲ +0.11 (+7.43%)
Open: 1.49 Vol: 69.96K Day's range: 1.49 - 1.665 Aug 14, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
NCNA Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 1.60▼ 1.59▼ 1.57▲ 1.48▲ 1.40▲
MA10 1.56▲ 1.53▲ 1.50▲ 1.43▲ 1.51▲
MA20 1.50▲ 1.48▲ 1.45▲ 1.36▲ 1.79▼
MA50 1.42▲ 1.38▲ 1.37▲ 1.52▲ 2.70▼
MA100 1.37▲ 1.36▲ 1.38▲ 1.76▼ 88.18▼
MA200 1.49▲ 1.68▼ 1.73▼ 2.41▼ 1,555.39▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.008▲ 0.013▲ 0.016▲ 0.041▲ 0.736▲
RSI 62.690▲ 63.921▲ 66.740▲ 63.063▲ 34.206▼
STOCH 78.885     88.046▲ 82.404▲ 55.659     17.711▼
WILL %R -37.209     -32.000     -32.000     -16.484▲ -67.797    
CCI 57.856     76.167     109.869▲ 149.120▲ -31.613    
Latest Filters Detected On NCNA
▲ MACD $NCNA MACD(12,26,9) Crossed Above Zero Set Alert
MA $NCNA Price Crossed Above MA(50) Set Alert
NuCana plc News
NuCana Reports Second Quarter 2026 Financial Results and Provides Business Update
Thursday, August 13, 2026 05:00 PM
EDINBURGH, United Kingdom, Aug. 13, 2026 (GLOBE NEWSWIRE)-- NuCana plc (NASDAQ: NCNA) ("NuCana” or the "Company”) today announced financial results for the second quarter ended June 30, 2026 and ...
NuCana's Encouraging Data From Resistant Melanoma Treatment Provides Some Relief After Disappointing Colorectal Cancer Data, Stock Surges
Monday, September 16, 2024 02:24 AM
On Saturday, NuCana plc (NASDAQ:NCNA) presented final data from the Phase 2 NuTide:701 study at the ESMO Congress on NUC-7738 in combination with Merck & Co Inc's (NYSE:MRK) Keytruda (pembrolizumab) ...
NuCana's Encouraging Data From Resistant Melanoma Treatment Provides Some Relief After Disappointing Colorectal Cancer Data, Stock Surges
Monday, September 16, 2024 02:24 AM
On Saturday, NuCana plc (NASDAQ:NCNA) presented final data from the Phase 2 NuTide:701 study at the ESMO Congress on NUC-7738 in combination with Merck & Co Inc's (NYSE:MRK) Keytruda (pembrolizumab) ...
NCNA historical stock data
date open high low close volume
14/08/26 1.49 1.665 1.49 1.59 69,958
13/08/26 1.4284 1.48 1.42 1.48 15,243
12/08/26 1.51 1.51 1.40 1.43 15,768
11/08/26 1.5941 1.5941 1.42 1.44 34,306
10/08/26 1.53 1.53 1.425 1.44 20,452
07/08/26 1.36 1.6599 1.34 1.47 200,384
06/08/26 1.31 1.36 1.285 1.36 15,508
05/08/26 1.39 1.39 1.30 1.34 25,913
04/08/26 1.37 1.40 1.362 1.39 8,775
03/08/26 1.3198 1.38 1.3198 1.35 26,657
Quote Details
52wk Low:1.21
52wk High:7.22
Vol:69.96K
Avg Vol(3m):878.6K
1Y Chng:-46.64%
1M Chng:+14.39%
Add to Watch List
More Information
Index US Composite
Market Cap. 6.16M